The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
The conflict is also triggering a widening public health emergency
Remidex manufactures micronutrient premixes and nutraceuticals,
Marks significant milestone for breakthrough biologic to treat rare blood cancers
The collaboration will leverage this clinical experience to inform NCEL-101 development, streamline regulatory pathways, and potentially accelerate timelines for achieving durable graft survival comparable to donor human islets
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations
Subscribe To Our Newsletter & Stay Updated
